EGFR GENE MUTATION

EGFR GENE MUTATION was reported 235 times

EGFR GENE MUTATION is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Kinase Inhibitor [EPC] 203 0.0006
1 Programmed Death Ligand-1 Blocker [EPC] 3 0.0004
2 Platinum-based Drug [EPC] 44 0.0003
3 Poly(ADP-Ribose) Polymerase Inhibitor [EPC] 3 0.0002
4 Microtubule Inhibitor [EPC] 15 0.0002
5 Programmed Death Receptor-1 Blocking Antibody [EPC] 15 0.0001
6 Vascular Endothelial Growth Factor Inhibitor [EPC] 12 0.0001
7 HER2/neu Receptor Antagonist [EPC] 4 0.0001
8 Epidermal Growth Factor Receptor Antagonist [EPC] 3 0.0001
9 Aromatase Inhibitor [EPC] 6 0.0001
10 Topoisomerase Inhibitor [EPC] 3 0.0001
11 Guanylate Cyclase-C Agonist [EPC] 1 0.0001
12 Nucleoside Metabolic Inhibitor [EPC] 10 0.0001
13 RANK Ligand Inhibitor [EPC] 7 0.0000
14 Sodium-Glucose Cotransporter 2 Inhibitor [EPC] 1 0.0000
15 Dihydropyridine Calcium Channel Blocker [EPC] 1 0.0000
16 Alkylating Drug [EPC] 3 0.0000
17 Vitamin D [EPC] 2 0.0000
18 Vitamin B12 [EPC] 2 0.0000
19 Vitamin C [EPC] 2 0.0000
20 Osmotic Laxative [EPC] 1 0.0000
21 Methylxanthine [EPC] 1 0.0000
22 HMG-CoA Reductase Inhibitor [EPC] 2 0.0000
23 Loop Diuretic [EPC] 2 0.0000
24 Central Nervous System Stimulant [EPC] 1 0.0000
25 GLP-1 Receptor Agonist [EPC] 1 0.0000
26 Proton Pump Inhibitor [EPC] 2 0.0000
27 Corticosteroid [EPC] 4 0.0000
28 beta-Adrenergic Blocker [EPC] 1 0.0000
29 Histamine-2 Receptor Antagonist [EPC] 1 0.0000
30 Folate Analog Metabolic Inhibitor [EPC] 1 0.0000
31 Thalidomide Analog [EPC] 1 0.0000
32 Nonsteroidal Anti-inflammatory Drug [EPC] 2 0.0000
33 Benzodiazepine [EPC] 1 0.0000
34 Platelet Aggregation Inhibitor [EPC] 1 0.0000